APA (7th ed.) Citation

V, B., U, S., P, G., C, L. M., I, Q., R, D., . . . G, Q. (2018). A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 13(7), e120. https://doi.org/10.1016/j.jtho.2018.03.004

Chicago Style (17th ed.) Citation

V, Basse, Schick U, Guéguen P, Le Maréchal C, Quintin-Roué I, Descourt R, Simon H, Uguen A, and Quéré G. "A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite No PD-L1 Expression." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 13, no. 7 (2018): e120. https://doi.org/10.1016/j.jtho.2018.03.004.

MLA (9th ed.) Citation

V, Basse, et al. "A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite No PD-L1 Expression." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 13, no. 7, 2018, p. e120, https://doi.org/10.1016/j.jtho.2018.03.004.